SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	489.05M +107.2%
Revenue (ttm)	696.19M +7.3%
Net Income	16.68M +29.8%
EPS	2.03 +29.8%
Shares Out	8.22M
PE Ratio	29.32
Forward PE	n/a
Dividend	1.20 (2.02%)
Ex-Dividend Date	Apr 28, 2026

Volume	982
Open	62.00
Previous Close	62.50
Day's Range	59.50 - 62.00
52-Week Range	38.00 - 72.50
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 723
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2025, SALUS, Ljubljana, d. d.'s revenue was 696.19 million, an increase of 7.30% compared to the previous year's 648.83 million. Earnings were 16.68 million, an increase of 29.78%.